The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(1-(3-amino-4-chloroisoxazolo[5,4-c]pyridin-7-yl)pyrrolidin-3-yl)-2-chloro-4-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)benzamide ID: ALA4095415
PubChem CID: 137653817
Max Phase: Preclinical
Molecular Formula: C23H20Cl2N6O3
Molecular Weight: 499.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(-c2ccc(C(=O)N[C@@H]3CCN(c4ncc(Cl)c5c(N)noc45)C3)c(Cl)c2)ccc1=O
Standard InChI: InChI=1S/C23H20Cl2N6O3/c1-30-10-13(3-5-18(30)32)12-2-4-15(16(24)8-12)23(33)28-14-6-7-31(11-14)22-20-19(17(25)9-27-22)21(26)29-34-20/h2-5,8-10,14H,6-7,11H2,1H3,(H2,26,29)(H,28,33)/t14-/m1/s1
Standard InChI Key: JQBSDZXMCJAJKM-CQSZACIVSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
20.2344 -19.0430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2332 -19.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9413 -20.2715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6509 -19.8621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6481 -19.0394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9395 -18.6341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5266 -18.6346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5264 -17.8174 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8190 -19.0433 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1112 -18.6349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0251 -17.8233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2258 -17.6536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8173 -18.3614 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3643 -18.9685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0066 -18.4488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5265 -17.7861 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7146 -17.8714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3817 -18.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6771 -19.1929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8633 -19.2854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6998 -20.0880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4126 -20.4915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0165 -19.9383 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9561 -20.4266 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9371 -17.8169 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.5688 -18.7029 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
22.3598 -20.2671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3581 -21.0822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0661 -21.4872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7723 -21.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7660 -20.2552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0575 -19.8539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4705 -19.8409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4824 -21.4803 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 2 0
7 9 1 0
10 9 1 1
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 10 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 20 1 0
19 15 1 0
13 15 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 1 0
21 24 1 0
6 25 1 0
18 26 1 0
4 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 1 0
31 32 1 0
32 27 2 0
31 33 1 0
30 34 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 499.36Molecular Weight (Monoisotopic): 498.0974AlogP: 3.49#Rotatable Bonds: 4Polar Surface Area: 119.28Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.61CX Basic pKa: 0.79CX LogP: 2.42CX LogD: 2.42Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.44Np Likeness Score: -1.42
References 1. Sakurada I, Endo T, Hikita K, Hirabayashi T, Hosaka Y, Kato Y, Maeda Y, Matsumoto S, Mizuno T, Nagasue H, Nishimura T, Shimada S, Shinozaki M, Taguchi K, Takeuchi K, Yokoyama T, Hruza A, Reichert P, Zhang T, Wood HB, Nakao K, Furusako S.. (2017) Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors., 27 (11): [PMID:28408226 ] [10.1016/j.bmcl.2017.03.002 ]